Crossmark

The role of drug regulatory authorities and health technology assessment agencies in shaping incentives for antibiotic R&D: a qualitative study

Crossref DOI link: https://doi.org/10.1186/s40545-023-00556-x

Published Online: 2024-03-11

Published Print: 2023-12-31

Update policy: https://doi.org/10.1080/tandf_crossmark_01

Authors

Kållberg, Cecilia https://orcid.org/0000-0003-1078-3128
Mathiesen, Liv

Gopinathan, Unni

Salvesen Blix, Hege
Funding

Funding for this research was provided by:

Innovative Medicines Initiative (115618 (DRIVE-AB))

Norwegian Institute of Public Health
License Information

Version of Record valid from 2023-12-31
More Information

Peer Review Statement: The publishing and review policy for this title is described in its Aims & Scope.

Aim & Scope: http://www.tandfonline.com/action/journalInformation?show=aimsScope&journalCode=jppp20

Publication History

Received: 2022-10-30

Accepted: 2023-03-13

Published: 2024-03-11